THE GLOBAL THREAT OF MULTI-DRUG RESISTANT TUBERCULOSIS*

1 Zhang Y B Heym Allen B The catalase-peroxidase gene and isoniazid resistance of M.tuberculosis. Nature 1992; 358:591-3.

2Piatek AS,Telenti A, Murray MR Genetotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 2000; 44:103-10.

3 Telenti A P Imboden Marchesi F Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341:647-50.

4Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53:536-48.

5 Drobniewski FA Molecular diagnosis Pozniak AL. resistance detection of drug of epidemiology tuberculosis. BrJ Hosp Med 1996; 56:204-8.

6Ormerod LP Chemotherapy of tuberculosis. Eur Resp J 1997; 2(4):273-97.

7 Iseman MD. Treatment of multi-drug resistant tuberculosis. N Engl J Med 1993; 329:784-91.

8 White VL Moore-Gillon J. Resource implications of patients with multidrug resistant tuberculosis. Thorax 2000; 55:962-3.

9 Espinal MA A Laszlo Simonsen L Global trends in resistance to antituberculosis drugs. N Engl J Med 2001; 344:1294-303.

10 Hayward AC DE Bennett Herbert J Risk factors for drug resistance in patients with tuberculosis in England and Wales 1993-4. Thorax 1996; 51(Suppl 3):A8.

11 Dye C MA Espinal ,Watt CJ Worldwide Incidence of Multidrug-Resistant Tuberculosis. J Infect Diseases 2002; 185:1197-2002.

12World Health Organization. Guidelines on the management of drug-resistant tuberculosis. Geneva: WHO; 1996; WHO/TB/96.210.

13 Goble M MD Iseman Madsen LA Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328:527-32.

14 Telzak EE K Sepkowitz ,Alpert P Multidrug resistant TB in patients without HIV infection. N Engl J Med 1995; 333:907-II.

15 Small PM Shafer RW Hopewell PC Exogenous reinfection with multi-drug resistant Mycobacterium tuberculosis in patients with advanced HIV disease. N Engj Med 1993; 328:1137-44.

16 Salomon N DC Perlman Fiedman P Predictors and outcome of multidrug resistant tuberculosis. Clin Infect Dis 1995; 21: 1245-52.

17 Herrera D R Cano Godoy P Multidrug-resistant tuberculosis outbreak on an HIV ward - Madrid, Spain, 1991-95. MMWR 1996;45:330-3.

18 Suarez PG K Floyd Portocarrero J Feasibility and cost-effectiveness of standardized second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet 2002; 359: 1980-9.